The effect of Arg(306) -> Ala and Arg(506) -> Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S

被引:45
作者
Egan, JO [1 ]
Kalafatis, M [1 ]
Mann, KG [1 ]
机构
[1] UNIV VERMONT,DEPT BIOCHEM,COLL MED,BURLINGTON,VT 05405
关键词
activated protein C; factor Va inactivation; protein S; recombinant factor V;
D O I
10.1002/pro.5560060922
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Factor Va (Na) is inactivated by activated protein C (APC) by cleavage of the heavy chain at Arg(306), Arg(506), and Arg(679). Site-directed mutagenesis of human factor V cDNA was used to substitute Arg(306) --> Ala (rfVa(306A)) and Arg(506) --> Gln (rfVa(506Q)). Both the single and double mutants (rfVa(306A/506Q)) were constructed. The activation of these procofactors by alpha-thrombin and their inactivation by APC were assessed in coagulation assays using factor V-deficient plasma. All recombinant and wild-type proteins had similar initial cofactor activity and identical activation products (a factor Va molecule composed of light and heavy chains). Inactivation of factor Va purified from human plasma (fVa(PLASMA)) in HBS Ca2+ +0.5% BSA or in conditioned media by APC in the presence of phospholipid vesicles resulted in identical inactivation profiles and displayed identical cleavage patterns. Recombinant wild-type factor Va (rfVa(WT)) was inactivated by APC in the presence of phospholipid vesicles at an overall rate slower than fVa(PLASMA). The rfVa(306A) and rfVa(506Q) mutants were each inactivated at rates slower than rfVa(WT) and fVa(PLASMA). Following a 90-min incubation with APC, rfVa(306A) and rfVa(506Q) retain approximately 30-40% of the initial cofactor activity. The double mutant, rfVa(306A/506Q), was completely resistant to cleavage and inactivation by APC retaining 100% of the initial cofactor activity following a 90-min incubation in the presence of APC. Recombinant fVa(WT), rfVa(306A), rfVa(506Q), rfVa(306A/506Q) were also used to evaluate the effect of protein S on the individual cleavage sites of the cofactor by APC. The initial rates of rfVa(WT) and rfVa(306A) inactivation in the presence of protein S were unchanged, indicating cleavage at Arg(506) is not affected by protein S. The initial rate of rfVa(506Q) inactivation was increased, suggesting protein S slightly accelerates the cleavage at Arg(306). Overall, the data demonstrate high specificity with respect to cleavage sites for APC on factor Va and demonstrate that cleavages of the cofactor at both Arg(306) Arg(506) are required for efficient factor Va inactivation.
引用
收藏
页码:2016 / 2027
页数:12
相关论文
共 58 条
[1]   Molecular mechanisms of activated protein C resistance - Properties of factor V isolated from an individual with homozygosity for the Arg(506) to Gin mutation in the factor V gene [J].
Aparicio, C ;
Dahlback, B .
BIOCHEMICAL JOURNAL, 1996, 313 :467-472
[2]  
BAJAJ SP, 1973, J BIOL CHEM, V248, P7729
[3]   SIMPLE METHOD FOR PREPARATION OF HOMOGENEOUS PHOSPHOLIPID VESICLES [J].
BARENHOLZ, Y ;
GIBBES, D ;
LITMAN, BJ ;
GOLL, J ;
THOMPSON, TE ;
CARLSON, FD .
BIOCHEMISTRY, 1977, 16 (12) :2806-2810
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]   THE FUNCTION OF THE HUMAN FACTOR-V CARBOHYDRATE MOIETY IN BLOOD-COAGULATION [J].
BRUIN, T ;
STURK, A ;
TENCATE, JW ;
CATH, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 170 (1-2) :305-310
[6]   PURIFICATION OF HUMAN VITAMIN-K-DEPENDENT PROTEIN-S AND ITS LIMITED PROTEOLYSIS BY THROMBIN [J].
DAHLBACK, B .
BIOCHEMICAL JOURNAL, 1983, 209 (03) :837-846
[7]   FAMILIAL THROMBOPHILIA DUE TO A PREVIOUSLY UNRECOGNIZED MECHANISM CHARACTERIZED BY POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - PREDICTION OF A COFACTOR TO ACTIVATED PROTEIN-C [J].
DAHLBACK, B ;
CARLSSON, M ;
SVENSSON, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1004-1008
[8]  
ESMON CT, 1979, J BIOL CHEM, V254, P964
[9]  
ESMON NL, 1982, J BIOL CHEM, V257, P859
[10]  
FAY PJ, 1991, J BIOL CHEM, V266, P8957